Bronfman gift to Mount Sinai catalyzes genomics-based medicine

New York, NYApril 6, 2007 -- The Andrea and Charles Bronfman Philanthropies (ACBP) have given $12.5 million to establish the Charles Bronfman Institute for Personalized Medicine at The Mount Sinai Medical Center. The Leadership Gift will help propel Mount Sinai to the forefront of personalized medicine, an emerging field that uses information about a persons genetic make-up to customize strategies for the detection, treatment, and prevention of disease. At the highest level, Mr. Bronfmans grant underscores the vital role philanthropy will play in advancing next-generation medical practice.

"Personalized medicine could be the most important scientific development of the 21st century," said Charles Bronfman, Chairman of the Andrea and Charles Bronfman Philanthropies. "In an industry like medicine, where market forces are slow to change, philanthropy must play the role of catalyst facilitating growth, inspiring awareness, and serving as a basis for change. The Mount Sinai Medical Center has been a pacesetter in the area of personalized medicine and is a clear choice for receiving this grant."

Personalized medicine transforms the traditional "one-size-fits-all" model of medicine by utilizing new methods of molecular analysis to better manage a patients disease or predisposition toward a disease. It represents a dramatic departure from "evidence-based medicine," which is based on population studies and has dominated medical principles for decades. While the evidence-based approach does allow doctors to modify treatment strategies according to a particular patient's response, it relies on trial-and-error and lacks precision. Personalized medicine, on the other hand, gives doctors an answer based on an individuals unique set of genes and thereby reduces uncertainty and error in diagnosis and treatment.

"The Mount Sinai Medical Center is poised to lead the most important medical revolution taking place today, and one that will have the big

Contact: Rich Polt
The Mount Sinai Hospital / Mount Sinai School of Medicine

Page: 1 2 3

Related biology news :

1. Climate change isolates Rocky Mountain butterflies
2. Bernese Mountain Dogs prone to Borrelia burgdorferi infection
3. NIH establishes Center of Excellence for influenza research at Mount Sinai
4. Mount Sinai School of Medicine licenses avian flu vaccine to Avimex
5. Sensational find: The mini-dinosaurs from the Harz Mountains
6. Brookhaven Lab and Mount Sinai form joint Center for Translational Biomedical Imaging
7. Mount Sinai School of Medicine and Bionostra Group collaborate to develop avian flu vaccine
8. University of Kentucky author captures national attention with Lost Mountain
9. Infectious disease expert warns of spread of Rocky Mountain spotted fever
10. Mount Sinai receives NIH funding for stem cell research
11. Enzyme deficiency may contribute to liver cancer, Mount Sinai research indicates

Post Your Comments:

(Date:8/26/2020)... (PRWEB) , ... August 25, ... ... clinical-stage biotechnology company developing novel pharmaceuticals targeting mitochondria, in partnership with Essex ... enrolment in its pivotal U.S. Phase 3 VISTA-2 study of SkQ1 ophthalmic ...
(Date:8/21/2020)... ... August 18, 2020 , ... ... today announced that the U.S. Food and Drug Administration (FDA) has approved the ... SBI-101, for the treatment of severe COVID-19. Approval of this IND allows Sentien ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... Princeton, NJ, have entered into license agreements with Housey Pharma’s HMI subsidiary to ... Roche and J&J have annual Research and Development spending in excess of US ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... ... August 03, 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands ... , Known as MediVet Biologics since its formation in 2016, the company is ... Animal Health will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... reliable, solid-state radar transmitter systems that can be configured to drive Klystrons, TWTs, ... controller that can drive one or two switches in a push-pull configuration; yielding ...
(Date:7/31/2020)... ... ... eSource has long been touted as the solution to high data management and monitoring ... did not take off as quickly as people initially expected, and where eSource is ... data electronically for clinical trials and then repurposing it for downstream analysis, at a ...
Breaking Biology Technology:
Cached News: